Pharmigene, Inc. (7595)
Market Closed
16 Oct, 05:30 AM
TWSE 
NT$
7. 25
0
0%
NT$
- Market Cap
- P/E Ratio
120% Div Yield
4,025 Volume
- Eps
NT$ 7.25
Previous Close Want to track 7595 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pharmigene, Inc. (7595) Statistics
Valuation metrics
Market Cap -
Enterprise value 922.3M
Trailing P/E (ttm) -7.12
Forward P/E -
PEG ratio -0.22
Price/Sales (ttm) 1.99
Price/Book (mrq) 1.43
Enterprise Value/Revenue 4.91
Enterprise Value/EBITDA -41.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 24.96K
Average volume (90 days) 42.61K
Price summary
52-Week low 5.9
52-Week high 11.85
Beta -
50-Day moving average 7.25
200-Day moving average 8.2
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 4:1
Last split Date 29 Sep 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.28%
Operating margin -0.24%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.74
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.84
Total debt (mrq) -
Total Debt/Equity (mrq) 2.45
Current ratio (mrq) 1.91%
Book value per share (mrq) 5.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
